Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30752935 | 1.00 | NR4A2 (0.53) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| Methane SCHEMBL28799503 | 0.98 | NR4A2 (0.51) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL30017691 | 0.85 | NR4A2 (0.53) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL155514 | 0.85 | NR4A2 (0.53) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL4577829 | 0.84 | NR4A2 (0.56) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL29773857 | 0.84 | NR4A2 (0.56) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL3839211 | 0.82 | NR4A2 (0.54) | NR4A2L3MBTL1GAAALDH1A1MAPT | |
| SCHEMBL25603748 | 0.82 | SLC6A3 (0.47) | NR4A2GAAALDH1A1MAPTHSD17B10 | |
| SCHEMBL289045 | 0.81 | ALDH1A1 (0.55) | ALDH1A1MAPTHSD17B10CA12CA1 | |
| SCHEMBL1378325 | 0.81 | CA12 (0.67) | NR4A2L3MBTL1GAAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115160134-B | Preparation method of 4-bromo-2-methyl benzoate | 无锡科华生物科技有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-217646394-U | A reation kettle for 4-bromo-2-methyl benzoate is synthetic | 上海率典医药科技有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115160134-A | Preparation method of 4-bromo-2-methyl benzoate | 无锡科华生物科技有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-114015905-B | Process for preparing nano-grade zirconium-based non-evaporable getter material | 安徽有研吸气材料有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-114015905-A | Process for preparing nano-grade zirconium-based non-evaporable getter material | 安徽有研吸气材料有限公司 | 2022-02-08 | — | — | CN | claimed |
| EP-3692101-B1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTR S R L (IT) | 2022-01-12 | — | — | EP | claimed |
| CN-113662941-A | Antiproliferative compounds and pharmaceutical compositions and uses thereof | 细胞基因公司 | 2021-11-19 | — | — | CN | claimed |
| CN-109553532-B | Preparation method of 4-bromoacetyl-2-methyl benzoic acid methyl ester | 荆门医药工业技术研究院 | 2021-04-02 | — | — | CN | claimed |
| EP-3692101-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | Alfa Instruments S.r.l. (IT) | 2020-08-12 | — | — | EP | claimed |
| WO-2019068935-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTRUMENTS S.R.L. (IT) | 2019-04-11 | — | — | WO | claimed |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| WO-2026102082-A1 | ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| CN-122055152-A | Combination therapy of FASN inhibitors with thyroid hormone receptor agonists | 萨吉米特生物科学公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132119-A1 | Alkylphenyl Substituted Compounds, Compositions and Methods of Use | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| CN-122029148-A | N-phenyl-3- (2, 5-dioxopyrrolidin-1-yl) propionamide derivatives and similar compounds as DUX4 inhibitors for the treatment of, for example, neuromuscular diseases | 阿勒泰治疗公司 | 2026-05-12 | — | — | CN | disclosed |
| WO-1995004716-A1 | 2-OXIMINOMETHYL-1-PHENYL-1,3-PROPANEDIONE DERIVATIVES AS HERBICIDES | RHONE-POULENC AGRICULTURE LTD (GB) | 1995-02-16 | — | — | WO | disclosed |
| EP-0299789-A1 | Mesomorphic compound having alkyl beta-hydroxycarboxylate as chiral group and liquid crystal composition containing same | MITSUBISHI RAYON CO., LTD. (JP) | 1989-01-18 | — | — | EP | disclosed |
| EP-0069810-B1 | NOVEL DIBENZOXEPINS, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THE USE OF DIBENZOXEPINS IN THE TREATMENT OF ALLERGIC CONDITIONS | MERCK & CO. INC. (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0069810-A1 | Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| US-4282365-A | Dibenz[b,e]oxepin compounds | MERCK & CO., INC. (US) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132119-A1 | Alkylphenyl Substituted Compounds, Compositions and Methods of Use | GIPR, MC2R, GRPR | NR4A2 2777/4885L3MBTL1 1493/4885GAA 633/4885 |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | DGAT2, DGAT1, DLAT | NR4A2 2151/4885L3MBTL1 991/4885GAA 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.